Pilot — Cell therapy

Choose the mechanism you can defend.

Denspath helps cell-therapy modeling teams compare plausible kinetic mechanisms, generate challenger models, and produce a reviewable evidence package before structural model decisions are locked.

Denspath sits upstream of NONMEM, Monolix, Pumas, and adjacent workflows. It strengthens the mechanism-comparison step — it does not replace the stack your team already trusts.

What a pilot produces

For one or two difficult datasets, Denspath delivers a reviewable mechanism package:

• Ranked candidate kinetic mechanism families
• Challenger models that test the leader’s assumptions
• Comparison of assumptions across top candidates
• Fit diagnostics and supporting rationale
• Next-measurement recommendation when candidates remain ambiguous
• Exportable artifacts for NONMEM, Monolix, and Pumas workflows

The goal is not autonomous model approval. The goal is a better, faster, more reviewable starting point for difficult cell-therapy model decisions.

Best-fit design partner

• 01Already uses quantitative modeling in a meaningful way
• 02Works on CAR-T or adjacent cell-therapy programs
• 03Has a technical champion responsible for model review
• 04Wants a workflow layer that complements the current stack
• 05Can run a fixed-scope pilot on one or two datasets

What we need from a partner

• One or two datasets where structural model choice is difficult or review-heavy
• A technical champion willing to compare Denspath output against the current process
• Enough biological and workflow context to define success criteria
• Periodic working sessions during the pilot